Health Canada Accepts Mitsubishi Tanabe’s Plant-Derived Flu Vaccine for Review

October 3, 2019
Medicago, a Canadian subsidiary of Mitsubishi Tanabe Pharma, said on October 1 that Health Canada has accepted for scientific review its plant-derived quadrivalent virus like particle (VLP) vaccine MT-2271. Mitsubishi Tanabe does not disclose the vaccine’s sales projection in Canada,...read more